Method for measuring anti-protease resistance of HIV-2 in a patient
US6794129B1 · kind B1 · utility
1Cited by
1References
22Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 20, 2002 |
| Grant date | Sep 21, 2004 |
| Priority date | — |
| Expiry date | Feb 20, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q1/703
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A search method in a biological sample containing an HIV 2 viral strain for possible resistance of said strain to treatment by an anti-protease agent, and nucleotide probes for the implementation thereof. According to methods known per se, the presence of at least one mutation at certain, specified, particular positions of the proteinic sequence of the protease of said viral strain from a biological sample taken from a patient contaminated by HIV 2 is searched. If said mutation is observed, the existence of a resistance to said anti-protease agent is assumed in the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.